Temperature management is vital in neurocritical care — for controlling fever, lowering brain metabolism, oxygen demand, and reducing intracranial pressure to protect the brain function after trauma, seizures, stroke, or oxygen deprivation. One of its most critical applications is targeted brain cooling, where lowering brain temperature helps prevent secondary injury and support recovery.
TEQCool transforms this field with non-invasive intranasal cooling, that has the potential to deliver faster, more precise temperature management that can halt oxidative stress and neurotoxic buildup (glutamate, potassium, calcium) which are key drivers of cellular damage during hypoxia or elevated temperature.
As the demand for advanced, patient-centered therapies grows —driven by critical care, surgery, and chronic neurological conditions, TEQCool sets the new standard in targeted brain cooling by offering a next-generation, patient-centered solution.
